Patent 7399746 was granted and assigned to McGill on July, 2008 by the United States Patent and Trademark Office.
The present invention relates to pharmaceutical compositions containing fragments of alpha-1 proteinase inhibitor (API) or chimeric proteins of API and insulin-like growth factor for use in stimulating wound healing.